Diversification and enrichment of clinical biomaterials inspired by Darwinian evolution
Source abstract
Abstract
Unlabelled Regenerative medicine and biomaterials design are driven by biomimicry. There is the essential requirement to emulate human cell, tissue, organ and physiological complexity to ensure long-lasting clinical success. Biomimicry projects for biomaterials innovation can be re-invigorated with evolutionary insights and perspectives, since Darwinian evolution is the original dynamic process for biological organisation and complexity. Many existing human inspired regenerative biomaterials (defined as a nature generated, nature derived and nature mimicking structure, produced within a biological system, which can deputise for, or replace human tissues for which it closely matches) are without important elements of biological complexity such as, hierarchy and autonomous actions. It is possible to engineer these essential elements into clinical biomaterials via bioinspired implementation of concepts, processes and mechanisms played out during Darwinian evolution; mechanisms such as, directed, computational, accelerated evolutions and artificial selection contrived in the laboratory. These dynamos for innovation can be used during biomaterials fabrication, but also to choose optimal designs in the regeneration process. Further evolutionary information can help at the design stage; gleaned from the historical evolution of material adaptations compared across phylogenies to changes in their environment and habitats. Taken together, harnessing evolutionary mechanisms and evolutionary pathways, leading to ideal adaptations, will eventually provide a new class of Darwinian and evolutionary biomaterials. This will provide bioengineers with a more diversified and more efficient innovation tool for biomaterial design, synthesis and function than currently achieved with synthetic materials chemistry programmes and rational based materials design approach, which require reasoned logic. It will also inject further creativity, diversity and richness into the biomedical technologies that we make. All of which are based on biological principles. Such evolution-inspired biomaterials have the potential to generate innovative solutions, which match with existing bioengineering problems, in vital areas of clinical materials translation that include tissue engineering, gene delivery, drug delivery, immunity modulation, and scar-less wound healing. Statement of significance Evolution by natural selection is a powerful generator of innovations in molecular, materials and structures. Man has influenced evolution for thousands of years, to create new breeds of farm animals and crop plants, but now molecular and materials can be molded in the same way. Biological molecules and simple structures can be evolved, literally in the laboratory. Furthermore, they are re-designed via lessons learnt from evolutionary history. Through a 3-step process to (1) create variants in material building blocks, (2) screen the variants with beneficial traits/properties and (3) select and support their self-assembly into usable materials, improvements in design and performance can emerge. By introducing biological molecules and small organisms into this process, it is possible to make increasingly diversified, sophisticated and clinically relevant materials for multiple roles in biomedicine.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Biomedical and Engineering Education · 3D Printing in Biomedical Research · Silk-based biomaterials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. The surprising origins of life’s complexity10.1038/scientificamerican0813-84 ↗
2. Biomimetic self-templated hierarchical structures of collagen-like peptide amphiphiles10.1021/acs.nanolett.5b03313 ↗
3. Biomimetic self-templating supramolecular structures10.1038/nature10513 ↗
4. Bryskin · Acta Biomater. · 2014 · 10 · 176110.1016/j.actbio.2014.01.019 ↗
5. Experimental evolution10.1016/j.tree.2012.06.001 ↗
6. Engineering complex tissues10.1126/scitranslmed.3004890 ↗
7. Self-organization and the self-assembling process in tissue engineering10.1146/annurev-bioeng-071812-152423 ↗
8. Strategies for organ level tissue engineering10.4161/org.6.3.12139 ↗
9. Biomaterial delivery of morphogens to mimic the natural healing cascade in bone10.1016/j.addr.2012.05.006 ↗
10. Exploring and engineering the cell surface interface10.1126/science.1106587 ↗
11. Complexity in biomaterials for tissue engineering10.1038/nmat2441 ↗
12. Mimicking biological phenomena in hydrogel-based biomaterials to promote dynamic cellular responses10.1039/C5TB01045D ↗
13. Engineering ECM signals into biomaterials10.1016/S1369-7021(12)70197-9 ↗
14. Wound repair and regeneration10.1038/nature07039 ↗
15. Inspiration and application in the evolution of biomaterials10.1038/nature08601 ↗
16. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy10.1038/nbt.3071 ↗
17. Bio-responsive polymer hydrogels homeostatically regulate blood coagulation10.1038/ncomms3168 ↗
18. Tailoring biomaterial surface properties to modulate host-implant interactions: implication in cardiovascular and bone therapy10.1039/C5TB01686J ↗
19. Mesoporous silica nanoparticles for the design of smart delivery nano devices10.1039/C2BM00085G ↗
20. Tissue engineering tools for modulation of the immune response10.2144/000113754 ↗
21. Engineering hydrogels as extracellular matrix mimics10.2217/nnm.10.12 ↗
22. Biomimetic electrospun nanofibrous structures for tissue engineering10.1016/j.mattod.2013.06.005 ↗
23. Designing ECM-mimetic materials using protein engineering10.1016/j.actbio.2013.12.028 ↗
24. Nanoscale engineering of extracellular matrix-mimetic bioadhesive surfaces and implants for tissue engineering
25. Tissue engineering: organs from the lab10.1038/522373a ↗
26. Designed biomaterials to mimic the mechanical properties of muscles10.1038/nature09024 ↗
27. Protein mechanics: from single molecules to functional biomaterials10.1021/ar100057a ↗
28. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering10.1038/nbt1055 ↗
29. Biomimetic materials in tissue engineering10.1016/S1369-7021(10)70013-4 ↗
30. Strategies for controlled delivery of growth factors and cells for bone regeneration10.1016/j.addr.2012.01.016 ↗
31. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments10.1098/rsif.2010.0223 ↗
32. Biodegradable silicon nanoneedles delivering nucleic acids intracellularly induce localised in vivo neovascularisation10.1038/nmat4249 ↗
33. Recent advances in nonviral vectors for gene delivery10.1021/ar200151m ↗
34. Delivery of siRNA therapeutics: barriers and carriers10.1208/s12248-010-9210-4 ↗
35. SiRNA versus miRNA as therapeutics for gene silencing10.1038/mtna.2015.23 ↗
36. Synthesis and evaluation of hetero- and homodimers of ribosome-targeting antibiotics: antimicrobial activity, in vitro inhibition of translation, and drug resistance10.1021/jm400707f ↗
37. Ribosome-targeting antibiotics and mechanisms of bacterial resistance10.1038/nrmicro3155 ↗
38. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications10.1016/S0924-8579(99)00121-1 ↗
39. Integrin targeted delivery of chemotherapeutics10.7150/thno/v01p0189 ↗
40. Hyaluronan/Hyaladherins – a promising axis for targeted drug delivery in cancer10.2174/1567201813666151109103013 ↗
41. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies10.1038/nrd4363 ↗
42. Targeted delivery systems for biological therapies of inflammatory diseases10.1517/17425247.2015.972931 ↗
43. Targeted delivery of an anti-cancer agent via steroid coupled liposomes10.3109/10717540903271391 ↗
44. Targeted estrogen delivery reverses the metabolic syndrome10.1038/nm.3009 ↗
45. Biomaterial strategies for immunomodulation10.1146/annurev-bioeng-071813-104814 ↗
46. Immune responses to implants – a review of the implications for the design of immunomoldulatory biomaterials10.1016/j.biomaterials.2011.05.078 ↗
47. Engaging adaptive immunity with biomaterials10.1039/C3TB21549K ↗
48. Engineering vaccines and niches for immune modulation10.1016/j.actbio.2013.12.036 ↗
49. Multivalent integrin-specific ligands enhance tissue healing and biomaterial integration10.1126/scitranslmed.3001002 ↗
50. The effect of integrin-specific bioactive coatings on tissue healing and implant osseointegration10.1016/j.biomaterials.2008.03.036 ↗
51. The ultrastructure of the plasma-sprayed hydroxyapatite-bone interface predisposing to bone bonding10.1016/S0142-9612(01)00177-6 ↗
52. Extracellular matrix as a biological scaffold material: structure and function10.1016/j.actbio.2008.09.013 ↗
53. Microstructures extracellular matrices in tissue engineering and development10.1016/j.copbio.2006.08.011 ↗
54. Materials as morphogenetic guides in tissue engineering10.1016/j.copbio.2003.09.004 ↗
55. Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial10.1016/j.actbio.2006.09.003 ↗
56. Regenerative medicine and developmental biology: the role of the extracellular matrix10.1002/ar.b.20081 ↗
57. Biomimetic approaches in bone tissue engineering: integrating biological and physicomechanical strategies10.1016/j.addr.2014.09.005 ↗
58. Biomimicry in biomedical research10.4161/org.23395 ↗
59. Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration10.1098/rsif.2006.0179 ↗
60. Regenerative healing, scar-free healing and scar formation across the species: current concepts and future perspectives10.1111/exd.12457 ↗
61. Tissue engineering and regenerative repair in wound healing10.1007/s10439-014-1010-z ↗
62. Biomimetic particles as therapeutics10.1016/j.tibtech.2015.07.001 ↗
63. Gold nanocages: from synthesis to theranostic applications10.1021/ar200061q ↗
64. Biomaterials-based nanofiber scaffold: targeted and controlled carrier for cell and drug delivery10.3109/1061186X.2014.992899 ↗
65. Genetically engineered nanofiber-like viruses for tissue regenerating materials10.1021/nl8036728 ↗
66. Fabrication of novel biomaterials through molecular self-assembly10.1038/nbt874 ↗
67. Bioartificial organs in the twenty-first century: nanobiological devices10.1111/j.1749-6632.2001.tb03856.x ↗
68. Tissue assembly and organization: developmental mechanisms in microfabricated tissues10.1016/j.biomaterials.2009.06.037 ↗
69. Biological and biomimetic molecular machines10.2217/17435889.3.1.107 ↗
70. Nanobiotechnology: the fabrication and applications of chemical and biological nanostructures10.1016/S0959-440X(00)00110-X ↗
71. Biomimetic materials for tissue engineering10.1016/j.addr.2007.08.041 ↗
72. Biomaterials for next generation materials
73. Biomimetism and bioinspiration as tools for the design of innovative materials and systems10.1038/nmat1339 ↗
74. Incorporation of a matrix metalloproteinase-sensitive substrate into self-assembling peptides – a model for biofunctional scaffolds10.1016/j.biomaterials.2007.11.046 ↗
75. Polymeric biomaterials with degradation sites for proteases involved in cell migration10.1021/ma981296k ↗
76. Bone regeneration mediated by biomimetic mineralization of a nanofiber matrix10.1016/j.biomaterials.2010.04.013 ↗
77. Evolving the use of peptides as components of biomaterials10.1016/j.biomaterials.2011.02.030 ↗
78. Designer D-form self-assembling peptide nanofiber scaffolds for 3-dimensional cell cultures10.1016/j.biomaterials.2013.03.081 ↗
79. Injectable MMP-sensitive alginate hydrogels as hMSC delivery systems10.1021/bm4016495 ↗
80. Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-210.1016/j.biomaterials.2010.06.061 ↗
81. Engineering biomolecular microenvironments for cell instructive biomaterials10.1002/adhm.201300603 ↗
82. Three-dimensional polymer constructs exhibiting a tunable negative Poisson’s ratio10.1002/adfm.201002022 ↗
83. How smart do biomaterials need to be? A translational science and clinical point of view10.1016/j.addr.2012.07.009 ↗
84. Integration column: artificial ECM: expanding the cell biology toolbox in 3D10.1039/b902243k ↗
85. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention10.1098/rstb.2004.1475 ↗
86. Transdifferentiation: a cell and molecular reprogramming process10.1007/s00441-012-1403-y ↗
87. Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine
88. Complement-triggered pathways orchestrate regenerative responses throughout phylogenesis10.1016/j.smim.2013.04.002 ↗
89. Survival of the cheapest10.1016/S1369-7021(02)01237-3 ↗
90. Synthesis and patterning of tunable multiscale materials with engineered cells10.1038/nmat3912 ↗
91. A systems biology perspective on rational design of peptide vaccine against virus infections10.2174/156802612801319043 ↗
92. The rational design of biological complexity: a deceptive metaphor10.1002/pmic.200600407 ↗
93. Platts · 2005 · 157
94. In silico evolution of functional morphology: a test on bone tissue biomechanics10.1098/rsif.2006.0128 ↗
95. Evolutionary design of bone scaffolds with reference to material selection10.1002/cnm.2487 ↗
96. Microfluidic 3D bone tissue model for high-throughput evaluation of wound-healing and infection-preventing biomaterials10.1016/j.biomaterials.2011.10.036 ↗
97. In vitro microvessels for the study of angiogenesis and thrombosis10.1073/pnas.1201240109 ↗
98. Ontogeny of the tessellated skeleton: insight from the skeletal growth of the round stingray Urobatis halleri10.1111/j.1469-7580.2009.01116.x ↗
99. Changing environments and structure-property relationships in marine biomaterials10.1242/jeb.058925 ↗
100. Frictional properties of contacting surfaces in the hemelytra-hindwing locking mechanism in the bug Coreus marginatus (Heteroptera, Coreidae)10.1007/s00359-004-0520-9 ↗